Results 141 to 150 of about 4,852 (207)

Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis. [PDF]

J Clin Transl Hepatol, 2021
Ma X, Liu S, Wang M, Wang Y, Du S, Xin Y, Xuan S.   +6 more
europepmc   +1 more source

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing

, 2021
Kelly A. Johnson, Xin Niu, David V. Glidden, José Castillo‐Mancilla, Jenna Yager, Samantha MaWhinney, Mary Morrow, Hideaki Okochi, Tim R. Cressey, Paul K. Drain, Monica Gandhi, Peter L. Anderson, Matthew A. Spinelli   +12 more
openalex   +1 more source

On-Demand HIV Pre-Exposure Prophylaxis Dose Finding Study for Insertive Sex in Young Men in Sub-Saharan Africa: Comparison of Emtricitabine-Tenofovir Disoproxil Fumarate and Emtricitabine-Tenofovir Alafenamide in an Open-Label Randomised Controlled Trial

, 2023
Carolina Herrera, Jennifer Serwanga, Laura Else, Limakatso Lebina, Daniel Opoka, Andrew S. Ssemata, Azure-Dee Pillay, Patricia Namubiru, Thabiso B. Seiphetlo, Geoffrey Odoch, Susan Mugaba, Portia Seatlholo, Amara Alieu, Sujan Dilly Penchala, Richard Muhumuza, Berenice Alinde, Stefan Petkov, Kyle O’Hagan, Christian Callebaut, Janet Seeley, Helen A. Weiss, Saye Khoo, Francesca Chiodi, Clive M. Gray, Pontiano Kaleebu, Emily Webb, Neil A. Martinson, Julie Fox   +27 more
openalex   +1 more source

Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial. [PDF]

BMC Pharmacol Toxicol
Yazdan Pouri N, Shokati Eshkiki Z, Talebi A, Cheraghian B, Ahmadi F, Neisi N, Shayesteh AA.   +6 more
europepmc   +1 more source

Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis

, 2020
Rochelle P. Walensky, Tim Horn, Nicole C. McCann, Kenneth A. Freedberg, A. David Paltiel   +4 more
openalex   +2 more sources

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis [PDF]

Calvin Q. Pan, Lin Zhu, Andy Yu, Yuchan Zhao, Bo Zhu, Erhei Dai   +5 more
openalex   +1 more source

Relationship between adherence to bictegravir/emtricitabine/tenofovir alafenamide fumarate and clinical outcomes in people with HIV in Japan: a claims database analysis. [PDF]

Sci Rep
Taguchi N, Piao Y, Rubino A, Lee K, Chen M, Harada K, Tanikawa T, Naito T.   +7 more
europepmc   +1 more source

Letter on “Efficacy and Safety of Tenofovir Alafenamide ( TAF ) and Tenofovir Disoproxil Fumarate ( TDF ) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment” [PDF]

Yan Liu, Liheng Wang, Li Li, Linli He
openalex   +1 more source

Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques. [PDF]

J Infect Dis
Makarova N, Singletary T, Peet MM, Mitchell J, Bachman S, Holder A, Dinh C, Lipscomb J, Agrahari V, Mendoza M, Pan Y, Heneine W, Clark MR, García-Lerma JG, Doncel GF, Smith JM.   +15 more
europepmc   +1 more source

Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-Word Cohort Study. [PDF]

Pathogens
Fülöp B, Fischer J, Hahn M, Böhlig A, Matz-Soja M, Berg T, van Bömmel F.   +6 more
europepmc   +1 more source